Discover MabDesign

MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.
carl-newton-2C6kAtCXf6U-unsplash

Access our network

Join the MabDesign network to take advantage of all the advantages and opportunities offered.
casey-horner-9vf1uj6i6Ww-unsplash

Develop your skills

Consult and register for our next training courses in order to acquire new expertise.
smartworks-coworking-Uz8THWPXwhI-unsplash

Explore our business services

The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.
arlington-research-kN_kViDchA0-unsplash

Upcoming events

Add your title here

17
Sep.
17-19 September 2024
Partner Event
25
Sep.
September 25-26 2024
Mabdesign Event
08
Oct.
8-10 October, 2024
Partner Event
10
Oct.
10-11 October 2024
Partner Event
15
Oct.
October 15-17, 2024
Partner Event
28
Oct.
28-31 October, 2024
Partner Event

Our News

Calvagone-Logo

Calvagone - new member

At Calvagone, we specialize in providing top-tier pharmacometrics consulting services, dedicated to supporting our customers throughout their drug development process.
AGS-Therapeutics-1-5-1-300x160-1

AGS Therapeutics Announces the Appointment of Dr. Renee T. Williams as an Independent Board Member

AGS Therapeutics Announces the Appointment of Dr. Renee T. Williams as an Independent Board Member
images

B2G Life Sciences - new member

B2G Life Sciences is a science-driven, international, medical consulting company, dedicated to clinical development.
2024_AbTx_Logo-Principal_Baseline_RVB-768x398

AbTx (Antibody for Therapy) - new member

AbTx (Antibody for Therapy) is an expert in the development of an enzymatic bio-conjugation technology that will enable the design and development of homogeneous, stable, high-quality conjugated antibodies and antibody fragments.

OUR BOARD OF DIRECTORS